BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1359042)

  • 1. Experience with a provocative test of calcitonin release as a prospective screening for preclinical medullary thyroid carcinoma in MEN type 2A family members.
    van Lathem JJ; Vermaak WJ; Kuyl JM; Mollentze W; Jansen S; Wolmarans L; Pelser H; Barry R; Kruger AJ; Wolfaardt M
    J Clin Lab Anal; 1992; 6(6):384-90. PubMed ID: 1359042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
    Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid venous catheterization in the early diagnosis of familial medullary thyroid carcinoma.
    Wells SA; Baylin SB; Johnsrude IS; Harrington DP; Mendelsohn G; Ontjes DJ; Cooper CW
    Ann Surg; 1982 Nov; 196(5):505-11. PubMed ID: 7125737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Provocative testing for occult medullary carcinoma of the thyroid: findings in seven children with multiple endocrine neoplasia type IIa.
    Graham SM; Genel M; Touloukian RJ; Barwick KW; Gertner JM; Torony C
    J Pediatr Surg; 1987 Jun; 22(6):501-3. PubMed ID: 2886576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
    Lips CJ; Landsvater RM; Höppener JW; Geerdink RA; Blijham G; van Veen JM; van Gils AP; de Wit MJ; Zewald RA; Berends MJ
    N Engl J Med; 1994 Sep; 331(13):828-35. PubMed ID: 7915822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
    Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
    J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic staging.
    Wells SA; Baylin SB; Gann DS; Farrell RE; Dilley WG; Preissig SH; Linehan WM; Cooper CW
    Ann Surg; 1978 Sep; 188(3):377-83. PubMed ID: 686900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of provocative tests in suspected medullary carcinoma of the thyroid:heterogeneity of calcitonin responses to calcium and pentagastrin.
    McLean GW; Rabin D; Moore L; Deftos LJ; Lorber D; McKenna TJ
    Metabolism; 1984 Sep; 33(9):790-6. PubMed ID: 6472115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients.
    Guyétant S; Josselin N; Savagner F; Rohmer V; Michalak S; Saint-André JP
    Mod Pathol; 2003 Aug; 16(8):756-63. PubMed ID: 12920219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multiple endocrine type 2 neoplasia in 3 families].
    Palchik M; Sánchez A; Góméz J; Rodríguez Pécora A
    Medicina (B Aires); 1990; 50(2):117-23. PubMed ID: 1983220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medullary thyroid carcinoma and calcitonin.
    Emmertsen K
    Dan Med Bull; 1985 Mar; 32(1):1-28. PubMed ID: 2859145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
    Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
    World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
    Costante G; Meringolo D; Durante C; Bianchi D; Nocera M; Tumino S; Crocetti U; Attard M; Maranghi M; Torlontano M; Filetti S
    J Clin Endocrinol Metab; 2007 Feb; 92(2):450-5. PubMed ID: 17119000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal and pentagastrin-stimulated calcitonin cut-off values in diagnosis of preoperative medullary thyroid cancer.
    Kartal Baykan E; Erdoğan M
    Turk J Med Sci; 2021 Apr; 51(2):650-656. PubMed ID: 33128357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer.
    Colombo C; Verga U; Mian C; Ferrero S; Perrino M; Vicentini L; Dazzi D; Opocher G; Pelizzo MR; Beck-Peccoz P; Fugazzola L
    J Clin Endocrinol Metab; 2012 Mar; 97(3):905-13. PubMed ID: 22170709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum calcitonin levels with calcium loading tests before and after total thyroidectomy in patients with thyroid diseases other than medullary thyroid carcinoma.
    Kudo T; Miyauchi A; Ito Y; Yabuta T; Inoue H; Higashiyama T; Tomoda C; Hirokawa M; Amino N
    Endocr J; 2011; 58(3):217-21. PubMed ID: 21358115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland.
    Wells SA; Baylin SB; Linehan WM; Farrell RE; Cox EB; Cooper CW
    Ann Surg; 1978 Aug; 188(2):139-41. PubMed ID: 686877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-sensitivity serum calcitonin assays applied to screening for thyroid C-cell disease in multiple endocrine neoplasia type 2A.
    Kaplan MM; Stall GM; Cummings T; MacAulay A; Motté P; Wolfe HJ; Reichlin S; Tashjian AH
    Henry Ford Hosp Med J; 1992; 40(3-4):227-31. PubMed ID: 1362411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia.
    Borchhardt KA; Heinzl H; Gessl A; Hörl WH; Kaserer K; Sunder-Plassmann G
    Kidney Int; 2006 Dec; 70(11):2014-20. PubMed ID: 17051143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience with presymptomatic screening of patients with C cell carcinoma of the thyroid gland].
    Frilling A; Röher HD; Ponder BA; Goretzki PE; Schlaghecke R; Reiners C
    Chirurg; 1993 Jan; 64(1):28-35. PubMed ID: 8094664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.